The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-βGang Wang, Junnian Zheng, Juan Li et al.|Cancer Biology & Therapy|2022Cited by 36
Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expressionLulu Han, Gang Wang, Yuxin Chen et al.|Cancer Biology and Medicine|2024Cited by 12